Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats

Japanese Journal of Pharmacology

Volumn 73, Issue 3, 1997, Pages 185-190

  Kanagawa, Ray ^a   Wada, Takeo ^a   Sanada, Tsukasa ^a   Ojima, Mami ^a   Inada, Yoshiyuki ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Angiotensin II receptor antagonist; Blood flow; Candesartan cilexetil (TCV 116); Enalapril; Spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN II ANTAGONIST; CANDESARTAN HEXETIL; ENALAPRIL;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART INDEX; HEART RATE; HEMODYNAMICS; INTESTINE BLOOD FLOW; KIDNEY BLOOD FLOW; LIVER BLOOD FLOW; MALE; MUSCLE BLOOD FLOW; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN BLOOD FLOW; RAT; SKIN BLOOD FLOW; SMALL INTESTINE; SPLEEN BLOOD FLOW; SPONTANEOUSLY HYPERTENSIVE RAT; STAINING; STOMACH BLOOD FLOW; SYSTEMIC VASCULAR RESISTANCE; TISSUE BLOOD FLOW; VASODILATATION;

EID: 0030994856     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.185     Document Type: Article

References (27)

1. Kostis JB: Angiotensin converting enzyme inhibitors in hypertension. Cardiovasc Drug Rev 7, 173-176 (1989)
2. Bao G, Gohlke P and Unger T: Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models. J Cardiovasc Pharmacol 20, Supp 9, S96-S99 (1992)
3. Inada Y, Tanabe M, Kawazoe K and Nishikawa K: Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3, 4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models. Jpn J Pharmacol 47, 311-322 (1988)
4. 1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats. Hypertens Res 19, 75-81 (1996)
5. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL and Timmermans PBMWM: Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 252, 726-732 (1990)
6. Inada Y, Wada T, Sibouta Y, Ojima M, Sanada T, Otsuki K, Itoh K, Kubo K, Kohara Y, Naka T and Nishikawa K: Antihypertensive effects of a highly potent, long-acting angiotensin II subtype-1 receptor antagonist, (±)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl]-1H-benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. J Pharmacol Exp Ther 268, 1540-1547 (1994)
7. Byyny RL: Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring. J Hypertens 13, Supp 1, S29-S33 (1995)
8. Kubo K, Kohara Y, Yoshimura Y, Inada Y, Shibouta Y, Furukawa Y, Kato T, Nishikawa K and Naka T: A new class of diacidic nonpeptide angiotensin II receptor antagonists. J Med Chem 36, 2343-2349 (1993)
9. Noda M, Shibouta Y, Inada Y, Ojima M, Wada T, Sanada T, Kubo K, Kohara Y, Naka T and Nishikawa K: Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist. Biochem Pharmacol 46, 311-318 (1993)
10. Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T and Nishikawa K: Pharmacological profile of a highly potent, long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylic acid (CV-11974), and its prodrug, (±)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylate (TCV-116). J Pharmacol Exp Ther 266, 114-120 (1993)
11. Ogihara T, Nagano M, Higaki J, Kohara K and Mikami H: Persistent inhibition of the pressor and aldosterone responses to angiotensin-II by TCV-116 in normotensive subjects. J Cardiovasc Pharmacol 26, 490-494 (1995)
12. Delacrétaz E, Nussberger J, Biollaz J, Waeber B and Brunner HR: Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. Hypertension 25, 14-21 (1995)
13. Okamoto K and Aoki K: Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27, 282-293 (1963)
14. Kowallik P, Schulz R, Guth BD, Schade A, Paffhausen W, Gross R and Heusch G: Measurement of regional myocardial blood flow with multiple coloured microspheres. Lab Invest 83, 974-982 (1991)
15. Hakkinen JP, Miller MW, Smith AH and Knight DR: Measurement of organ blood flow with coloured microspheres in the rat. Cardiovasc Res 29, 74-79 (1995)
16. Tabrizchi R, Pang CCY and Walker MJA: Effects of anipamil on cardiovascular status and regional blood flow in anaesthetized rats. Br J Pharmacol 98, 1185-1190 (1989)
17. Koike H, Ito K, Miyamoto M and Nishino H: Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ14,225) on hemodynamics and circulating blood volume in SHR. Hypertension 2, 299-303 (1980)
18. Giudicelli JF, Richer C, Richer C and Thuillez C: Angiotensin converting enzyme inhibition. Systemic and regional haemodynamics in rats and human. Am J Hypertens 4, 258S-262S (1991)
19. Oizumi K, Sada T, Miyake S and Koike H: Central and peripheral effects of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in SHR. Jpn Pharmacol Ther 20, 31-36 (1992) (Abstr in English)
20. Wang Y, Gavras I, Wierzba and Gavras H: Comparison of systemic and regional haemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats. J Lab Clin Med 119, 267-272 (1992)
21. Ito K, Shiomi M and Kito G: Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and regional haemodynamics in dogs with renal hypertension. Hypertens Res 18, 69-75 (1995)
22. Freeman RH, Davis JO, Vitale SJ and Johnson JA: Intrarenal role of angiotensin II. Homeostatic regulation of renal blood flow in the dog. Circ Res 32, 692-698 (1973)
23. Cowley AW, Roman RJ, Fenoy FJ and Mattson DL: Effect of renal medullary circulation on arterial pressure. J Hypertens 10 Supp 7, S187-S193 (1992)
24. Hollenberg NK, Coletti C and Passan D: Hypertension, volume and vasoconstriction: Studies on the renal blood supply in SHR, WKY, and DOCA-salt rat models. Hypertens Res 15, 3-11 (1992)
25. Hollenberg NK, Swartz SL, Passan DR and Williams GH: Increased glomerular nitration rate after converting enzyme inhibition in essential hypertension. N Engl J Med 301, 9-12 (1979)
26. Pelayo JC, Quan AH and Shanley PF: Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am J Physiol 258, F414-F422 (1990)
27. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I and Fogo A: Blood pressure-independent effect of angiotensin inhibition on vascular lesion of chronic failure. Kidney Int 42, 46-55 (1992)